2h
Zacks Investment Research on MSNGilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should KnowGilead Sciences (GILD) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some ...
Tomas Cihlar knew all too well that despite initial successes with combination treatment, HIV was firmly holding ground ...
5d
The Marion Star on MSN2025 boys track preview: Mount Gilead using its numbers, depth, talent for title runsHere is an overview of the Marion area's boys track season before it starts this weekend. See who looks strong for 2025.
Hulu announced that it is developing a series based on Margaret Atwood's 2019 novel "The Testaments," which is a follow-up to ...
PEPFAR had been set to lead the rollout of Gilead Science's lenacapavir, which has been hailed as a "miracle" of HIV ...
Protagonist (Nasdaq: PTGX) is one of a handful of Bay Area drug developers ready to ask the Food and Drug Administration to ...
Explore more
Scientifically, Denali's milestone filing is important because it shows the potential of the company's enzyme transport ...
Gilead CEO Daniel O’Day saw another rise in his pay in 2024, reflecting the steadily upward trajectory of the company since ...
Welcome back to Gilead. “The Handmaid’s Tale” sequel series “The Testaments” has officially received a series order from Hulu ...
‘The Handmaid’s Tale’ Sequel Series ‘The Testaments’ Officially Greenlit At Hulu As 9 Round Out Cast
The Testaments also rounds out its cast with 9 new actors: Mabel Li, Amy Seimetz, Brad Alexander, Zarrin Darnell-Martin, Eva ...
Gilead markets several single-tablet regimens for HIV, and its next-generation products with better long-term safety profiles, led by Biktarvy, are boosting the company's market share.
Bruce Miller knew for a long time how he wanted to bring the story to a conclusion,' says EP Eric Tuchman. 'It's about June's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results